NCT07389642Active, not recruiting
Brain Oligometastasis in NSCLC
Management of Patients With Brain-onset Oligometastatic Non-small-cell Lung Cancer (NSCLC)
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
75-80% of NSCLC are diagnosed at the metastatic stage. Among the most frequent sites are brain metastases. The management of patients with exclusive limited brain involvement is not standardized. The question is therefore which therapeutic strategy is optimal in such disease presentation. We will analyze the impact of different therapeutic strategies on patients treated at Bordeaux University Hospital and the Bergonié Institute
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 46 (actual)
- First submitted
- 28 Jan 2026
- Start date
- 1 Jan 2025
- Primary completion date
- Mar 2026
- Lead sponsor
- University Hospital, Bordeaux
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT07389642
What you commit to
- Study type: Observational
- Participants enrolled: 46
- From 1 Jan 2025 to the primary completion date, Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient with concomitant cancer
- Patient with prior treatment for lung cancer in the year preceding diagnosis at metastatic stage
Lab values
- Oncogenic addiction EGFR, ALK, ROS1
Who the study is looking for
- Consecutive patients managed at Bordeaux University Hospital
- Non-small-cell lung cancer
- Oligometastatic brain cancer (fewer than 5 lesions at diagnosis)
- Patient over 18 years old
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Bordeaux Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.